Are you or someone you care about wondering if therapy might be helpful? Maybe you've thought, "I don't want to feel like this anymore, but I don't know what to do," or "Something just doesn’t feel ...

Pathologists at the Stanford University School of Medicine are trying out a new test from a Sunnyvale company that could give cancer patients a better chance of getting the most effective treatment.

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, today announced the ...

Affymetrix Inc. and PathWork Informatics Inc. have announced that Affymetrix has granted PathWork long-term non-exclusive access to its microarray technology to develop and market in-vitro diagnostic ...

Redwood City, CA, October 30, 2012 – Pathwork Diagnostics, Inc., the innovator of the Pathwork® Tissue of Origin Test and a pioneer in creating genomics-based diagnostics in oncology, today announced ...

Federal regulators said Thursday that they have given Pathwork Diagnostics of Sunnyvale permission to begin selling a new genetic test to determine what type of cancer cells are in a malignant tumor.

Whether you’re a teenager, or raising one, adolescence is no joke. This transitional period can test relationship limits and leave teens and parents feeling hurt, confused, scared, and an array of ...

Pathwork Diagnostics Inc., has announced that it has entered into a research collaboration with Novartis. The parties intend to discover clinically meaningful biomarker signatures that can serve as ...

SUNNYVALE, Calif., Sept. 4 Pathwork Diagnostics, amolecular diagnostics company focused on oncology, announced the closing todayof a $20 million financing led by Abingworth. The announcement came on ...